NIH | National Cancer Institute | NCI Wiki  

Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.
Comment: Updated to reflect UI changes apparently released with STRAP-130.

The following table lists and describes some of the data elements displayed in the Milestone Report report for each milestone.

Data ElementDescription
NCI ID

The trial to which the milestone applies

, identified by the number assigned to that trial by the National Cancer Institute.

. The

Include Page
Trial Attribute NCI ID - Include v4.4
Trial Attribute NCI ID - Include v4.4

MilestoneThe name of the milestone. For information, refer to Processing Trial Milestones.
Milestone DateThe date and time CTRO added the milestone.
User NameThe CTRO user who added the milestone.
Submission Type

The submission type of the trial to which the milestone applies,

whether the trial is an original submission or an amendment.

Include Page
Trial Attribute Submission Type OA - Include v4.4
Trial Attribute Submission Type OA - Include v4.4
For information, refer to Processing Trial History Information.

Trial Category

The category of the trial to which the milestone applies. The

Include Page
Trial Attribute Study Source Category - Include v4.4
Trial Attribute Study Source Category - Include v4.4
 For information, refer to CTRP Trial Categories, Study Sources or Abstracting NCI-Specific Information

Trial Category

The Data Table 4 Funding Sponsorship or Trial Submission Category (study source): Complete or Abbreviated

.

No of SubmissionIf the trial submitter amended the trial, this number indicates the

The submission to which the milestone applies

. An original submission is submission 1

, as a

Include Page
Trial Attribute Submission Number - Include v4.4
Trial Attribute Submission Number - Include v4.4
For information, refer to Processing Trial History Information.

Trial/Study Type

The

trial type: Interventional or Non-interventional.

Trial Sub Type

The trial sub type: Observational or Ancillary Correlative. A sub type is available only for Non-interventional trials.

Include Page
Trial Attribute Trial Type - Include v4.4
Trial Attribute Trial Type - Include v4.4
 For information, refer to Trial Types and Subtypes, Abstracting Interventional Trial Design, or Abstracting Non-Interventional Trial Design.

Trial Subtype

The

Include Page
Trial Attribute Trial Subtype - Include v4.4
Trial Attribute Trial Subtype - Include v4.4
 For information, refer to Trial Types and Subtypes or Abstracting Non-Interventional Trial Design

Primary Purpose

The

Include Page
Trial Attribute Primary Purpose - Include v4.4
Trial Attribute Primary Purpose - Include v4.4
For information, refer to Primary Purpose Value DefinitionsAbstracting Interventional Trial Design, or Abstracting Non-Interventional Trial Design

Primary Purpose

The primary reason for conducting the trial

.

Primary Purpose Other Text

The

Any text entered for the trial,

if the

as

Include Page
Trial Attribute Primary Purpose Other Text - Include v4.4
Trial Attribute Primary Purpose

is Other

Other Text - Include v4.4
For information, refer to Abstracting Interventional Trial Design or Abstracting Non-Interventional Trial Design.

Secondary Purpose

The

secondary reason for conducting the trial

Include Page
Trial Attribute Secondary Purpose - Include v4.4
Trial Attribute Secondary Purpose - Include v4.4
For information, refer to Abstracting Interventional Trial Design.

Secondary Purpose Other Text

The

Any text entered for the trial,

if the

as

Include Page
Trial Attribute Secondary Purpose Other Text - Include v4.4
Trial Attribute Secondary Purpose

is

Other Text - Include v4.4
For information, refer to Abstracting Interventional Trial Design.

Lead Organization

The lead organization on the trial to which CTRO added the milestone.

 

The

Include Page
Trial Attribute Lead Org Name - Include v4.4
Trial Attribute Lead Org Name - Include v4.4
For information, refer to Abstracting Sponsors and Responsible Parties.

CommentsAny comments that have been entered for the milestone.